M. Dumont

Validation of an HPLC method for the determination of CP-93,393 in CP-93,393-1 tablets.

R. Reed, M. Dumont, S. Colgan, 1998, Journal of pharmaceutical and biomedical analysis.

(1S,2S)-1-(4-Hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1- propanol: A Potent New Neuroprotectant Which Blocks N-Methyl-D- aspartate Responses.

F. Menniti, W. White, M. Collins, 1995 .

Synthesis of high-specific activity tritium and optically pure [14C]CP-101,606. Enantioselective crystallization of a radiochemically racemic mixture

S. Miller, K. E. Mccarthy, M. Dumont, 1997 .

(1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses.

M. Collins, M. Dumont, J. Bordner, 1995, Journal of medicinal chemistry.

Probability of passing dissolution acceptance criteria for an immediate release tablet.

B. Nickerson, M. Dumont, Mark R Berry, 2007, Journal of pharmaceutical and biomedical analysis.

Validation of a dissolution method with HPLC analysis for lasofoxifene tartrate low dose tablets.

B. Nickerson, M. Dumont, Mark R Berry, 2007, Journal of pharmaceutical and biomedical analysis.

Assay and purity evaluation of sunepitron hydrochloride by reversed-phase liquid chromatography using a reference standard composite.

S. G. Ruggeri, M. Dumont, S. Colgan, 1998, Journal of pharmaceutical and biomedical analysis.